Quality, Value, Momentum Scores
This card shows the Quality, Value, and Momentum scores for the company
Income Statement: Revenue, Operating Income, Net Income
- The revenue for Cinclus Pharma Holding AB (publ) as of 30 June 2025 is 38.67 MM.
- The operating income for Cinclus Pharma Holding AB (publ) as of 30 June 2025 is -188.75 MM.
- The net income for Cinclus Pharma Holding AB (publ) as of 30 June 2025 is -172.93 MM.
| Period End (TTM) | Revenue (MM) | Operating Income (MM) | Net Income (MM) |
| 2025-06-30 | 38.67 | -188.75 | -172.93 |
| 2025-03-31 | 4.58 | -180.18 | -164.81 |
| 2024-12-31 | 4.58 | -168.93 | -168.03 |
| 2024-09-30 | 0.00 | -151.81 | -157.91 |
| 2024-06-30 | 0.00 | -174.73 | -183.32 |
| 2024-03-31 | 2.95 | -187.48 | -202.83 |
| 2020-12-31 | -39.29 | -42.94 |
Income Statement: EPS
| Period End (TTM) | Earnings Per Share Basic | Earnings Per Share Diluted |
| 2025-06-30 | ||
| 2025-03-31 | -3.91 | -3.91 |
| 2024-12-31 | -4.54 | -4.54 |
| 2024-09-30 | -4.94 | -4.94 |
| 2024-06-30 | -6.83 | -6.82 |
| 2024-03-31 | -7.73 | -7.73 |
| 2020-12-31 | -173.37 |
Cash Flow: Operations, Investing, Financing
- The cash from operating activities for Cinclus Pharma Holding AB (publ) as of 30 June 2025 is -98.81 MM.
- The cash from investing activities for Cinclus Pharma Holding AB (publ) as of 30 June 2025 is -0.29 MM.
- The cash from financing activities for Cinclus Pharma Holding AB (publ) as of 30 June 2025 is -0.08 MM.
| Period End (TTM) | Cash From Operating Activities (MM) | Cash From Investing Activities (MM) | Cash From Financing Activities (MM) |
| 2025-06-30 | -98.81 | -0.29 | -0.08 |
| 2025-03-31 | -184.66 | 655.19 | |
| 2024-12-31 | -178.37 | 655.20 | |
| 2024-09-30 | -162.88 | 655.47 | |
| 2024-06-30 | -166.55 | 743.02 | |
| 2024-03-31 | -197.86 | 122.88 | |
| 2020-12-31 | -39.47 | -0.07 | 233.46 |
Valuation Metrics : PE, PriceToBook, PriceToTBV
- The p/e for Cinclus Pharma Holding AB (publ) as of 30 June 2025 is -4.48.
- The p/book for Cinclus Pharma Holding AB (publ) as of 30 June 2025 is 1.44.
- The p/tbv for Cinclus Pharma Holding AB (publ) as of 30 June 2025 is 1.44.
- P/Book
- The current closing price divided by the book value per share.
- P/TBV
- The current price divided by the tangible book value per share.
| Period End (TTM) | p/e | P/Book | P/TBV |
| 2025-06-30 | -4.48 | 1.44 | 1.44 |
| 2025-03-31 | -3.24 | 0.98 | 0.98 |
| 2024-12-31 | -6.04 | 1.57 | 1.57 |
| 2024-09-30 | -7.84 | 2.25 | 2.25 |
| 2024-06-30 | |||
| 2024-03-31 | -5.66 | -5.66 | |
| 2020-12-31 |
Valuation Metrics : EBitToEv, EBit3YrAvgToEv
- The ebit/ev for Cinclus Pharma Holding AB (publ) as of 30 June 2025 is -0.76.
- The ebit (3y)/ev for Cinclus Pharma Holding AB (publ) as of 30 June 2025 is -0.54.
| Period End (TTM) | EBIT/EV | EBIT (3y)/EV |
| 2025-06-30 | -0.76 | -0.54 |
| 2025-03-31 | 7.53 | 2.51 |
| 2024-12-31 | -0.51 | -0.17 |
| 2024-09-30 | -0.24 | -0.08 |
| 2024-06-30 | ||
| 2024-03-31 | 0.00 | 0.00 |
| 2020-12-31 |
Management Effectiveness
- The roa for Cinclus Pharma Holding AB (publ) as of 30 June 2025 is -0.24.
- The roe for Cinclus Pharma Holding AB (publ) as of 30 June 2025 is -0.27.
- The roic for Cinclus Pharma Holding AB (publ) as of 30 June 2025 is -0.32.
- The croic for Cinclus Pharma Holding AB (publ) as of 30 June 2025 is 0.92.
- The ocroic for Cinclus Pharma Holding AB (publ) as of 30 June 2025 is -0.36.
| Period End (TTM) | ROA | ROE | ROIC | CROIC | OCROIC |
| 2025-06-30 | -0.24 | -0.27 | -0.32 | 0.92 | -0.36 |
| 2025-03-31 | -1.78 | -0.30 | 0.86 | -0.32 | |
| 2024-12-31 | -0.26 | 0.81 | -0.27 | ||
| 2024-09-30 | -0.29 | 0.90 | -0.26 | ||
| 2024-06-30 | -3.74 | -1.37 | -3.65 | ||
| 2024-03-31 | 0.00 | 0.00 | 0.00 | ||
| 2020-12-31 |
Gross Margins
- The gross margin for Cinclus Pharma Holding AB (publ) as of 30 June 2025 is 1.00.
- The net margin for Cinclus Pharma Holding AB (publ) as of 30 June 2025 is -35.98.
- The operating margin for Cinclus Pharma Holding AB (publ) as of 30 June 2025 is -39.34.
- Gross Margin
- The Gross Margin is the ratio of revenue left after substracting the Cost of Goods Sold. It is calculated as 1.0 - (Revenue - COGS ) / Revenue.
- Net Margin
- The Net Margin (aka Profit Margin) is the ratio of revenue left after substracting the Net Income. It is calculated as Net Income / Revenue.
- Operating Margin
- The Operaing Margin is the ratio of revenue left after substracting the Operating Income. It is calculated as Operating Income / Revenue.
| Period End (TTM) | Gross Margin | Net Margin | Operating Margin |
| 2025-06-30 | 1.00 | -35.98 | -39.34 |
| 2025-03-31 | 1.00 | -36.69 | -37.04 |
| 2024-12-31 | |||
| 2024-09-30 | |||
| 2024-06-30 | 1.00 | -68.71 | -63.51 |
| 2024-03-31 | |||
| 2020-12-31 |
Identifiers and Descriptors
| Central Index Key (CIK) |
